Respiratory Syncytial Virus (RSV) Infection Treated by Ribavirin During an Allogeneic Haematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukaemia (AML)

Incidence and reasons for late failure after allogeneic haematopoietic cell transplantation following BuCy2 in acute myeloid leukaemia

10.1111/j.1365-2141.2009.07947.x ◽

2010 ◽

Vol 148 (4) ◽

pp. 623-626 ◽

Cited By ~ 2

Author(s):

Shubham Pant ◽

Mehdi Hamadani ◽

Anthony J. Dodds ◽

Jeffrey Szer ◽

Pamela A. Crilley ◽

...

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cell Transplantation ◽

Haematopoietic Cell ◽

Late Failure ◽

Second allogeneic haematopoietic cell transplantation using HLA‐matched unrelated versus T‐cell replete haploidentical donor and survival in relapsed acute myeloid leukaemia

10.1111/bjh.17426 ◽

2021 ◽

Author(s):

Mohamed A. Kharfan‐Dabaja ◽

Myriam Labopin ◽

Eolia Brissot ◽

Nicolaus Kroger ◽

Jürgen Finke ◽

...

Keyword(s):

T Cell ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cell Transplantation ◽

Haematopoietic Cell ◽

Monitoring of post-transplantCBFB-MYH11as minimal residual disease, rather thanKITmutations, can predict relapse after allogeneic haematopoietic cell transplantation in adults with inv(16) acute myeloid leukaemia

10.1111/bjh.14340 ◽

2016 ◽

Vol 180 (3) ◽

pp. 448-451 ◽

Cited By ~ 11

Author(s):

Fei-Fei Tang ◽

Lan-Ping Xu ◽

Xiao-Hui Zhang ◽

Huan Chen ◽

Yu-Hong Chen ◽

...

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Minimal Residual Disease ◽

Cell Transplantation ◽

Residual Disease ◽

Haematopoietic Cell ◽

Minimal Residual ◽

Isocitrate dehydrogenase inhibitor‐driven differentiation may resemble secondary graft failure in post‐allogeneic haematopoietic cell transplantation relapsed acute myeloid leukaemia

10.1111/bjh.17573 ◽

2021 ◽

Author(s):

Adrianne Rasche ◽

Emily F. Mason ◽

Stephen A. Strickland ◽

Michael Byrne ◽

P. Brent Ferrell

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cell Transplantation ◽

Isocitrate Dehydrogenase ◽

Graft Failure ◽

Haematopoietic Cell ◽

Allogeneic haematopoietic cell transplantation for adult acute myeloid leukaemia in second remission: a retrospective study of the Adult Acute Myeloid Leukaemia Working Group of the Japan Society for Haematopoietic Cell Transplantation (JSHCT)

10.1111/bjh.15399 ◽

2018 ◽

Vol 182 (2) ◽

pp. 245-250

Author(s):

Takaaki Konuma ◽

Masamitsu Yanada ◽

Satoshi Yamasaki ◽

Yachiyo Kuwatsuka ◽

Takahiro Fukuda ◽

...

Keyword(s):

Retrospective Study ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cell Transplantation ◽

Working Group ◽

Japan Society ◽

Haematopoietic Cell ◽

The haematopoietic cell transplantation comorbidity index score is predictive of early death and survival in patients over 60 years of age receiving induction therapy for acute myeloid leukaemia.

10.1111/j.1365-2141.2006.06476.x ◽

2007 ◽

Vol 136 (4) ◽

pp. 624-627 ◽

Cited By ~ 164

Author(s):

Francis J. Giles ◽

Gautam Borthakur ◽

Farhad Ravandi ◽

Stefan Faderl ◽

Srdan Verstovsek ◽

...

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cell Transplantation ◽

Induction Therapy ◽

Early Death ◽

Index Score ◽

Haematopoietic Cell ◽

Comorbidity Index ◽

Faculty Opinions recommendation of Haematopoietic cell transplantation with and without sorafenib maintenance for patients with FLT3-ITD acute myeloid leukaemia in first complete remission.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726774118.793548561 ◽

2018 ◽

Author(s):

Stephen Nimer

Keyword(s):

Complete Remission ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cell Transplantation ◽

Haematopoietic Cell ◽

First Complete Remission ◽

Haematopoietic cell transplantation with and without sorafenib maintenance for patients withFLT3-ITD acute myeloid leukaemia in first complete remission

10.1111/bjh.14260 ◽

2016 ◽

Vol 175 (3) ◽

pp. 496-504 ◽

Cited By ~ 99

Author(s):

Andrew M. Brunner ◽

Shuli Li ◽

Amir T. Fathi ◽

Martha Wadleigh ◽

Vincent T. Ho ◽

...

Keyword(s):

Complete Remission ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cell Transplantation ◽

Haematopoietic Cell ◽

First Complete Remission ◽

Faculty Opinions recommendation of Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717958906.793462914 ◽

2012 ◽

Author(s):

Nelson Chao

Keyword(s):

Complete Remission ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cell Transplantation ◽

Reduced Intensity Conditioning ◽

Open Label ◽

Phase 3 ◽

First Complete Remission ◽

Reduced Intensity ◽

163: Clofarabine Pre-Conditioning Prior to Allogeneic Stem Cell Transplantation in High Risk Acute Myeloid Leukaemia (AML): A Well Tolerated Regimen with Both Full and Reduced Toxicity Schedules

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2007.12.172 ◽

2008 ◽

Vol 14 (2) ◽

pp. 61

Author(s):

D.S. Richardson ◽

C. Hurlock ◽

K. Hill ◽

J. Newman ◽

N. McKeag ◽

...

Keyword(s):

Stem Cell ◽

High Risk ◽

Stem Cell Transplantation ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cell Transplantation ◽

Allogeneic Stem Cell Transplantation ◽

Reduced Toxicity ◽